There have been inconsistent reports regarding the relationship between the iron status and coronary vascular diseases (CVD). Recently, low serum iron levels have been shown to be associated with mortality from CVD in women.
of stored iron. Because the risk of CVD in women increases equally following natural or surgical menopause, regardless of whether the ovarian function and estrogen production are preserved [2] [3] [4] , uterine factors, particularly regular menstrual blood losses associated a relative iron deficiency, rather than endogenous hormone production may be responsible protecting premenopausal women against CVD 1, 5) . That concept, known as the iron hypothesis, gained additional support when correlations between elevated serum iron 5, 6) and ferritin levels 7, 8) and cardiovascular disease were reported in Caucasian populations. Experimental mated glomerular filtration rate (eGFR) was determined using the equation recommended by the Japanese Society for Nephrology 24) . Women with a hemoglobin level of ＜12 g/dl were considered to be anemic 25) . The data are presented as the mean±SD, unless otherwise noted. Due to its deviation from a normal distribution, the hsCRP level was logarithmically transformed for the analysis. Differences between two groups were analyzed using t-tests, and the frequencies of conditions were analyzed using the Chi-square test. Differences between three groups were analyzed using an analysis of variance. When the p values in the analysis of variance were p＜0.05, Bonferroni's multiple comparison procedure was performed. Bivariate correlations between the iron levels and the cardiometabolic parameters were evaluated using Pearson correlation analyses. Stepwise multiple regression analyses were performed to further indentify the most significant variables contributing to variations in the iron levels. A two-tailed P value of ＜0.05 was considered to be statistically significant. All calculations were performed using the SPSS system 15.0 software package (SPSS Inc., Chicago, IL).
Results
BMI and the serum albumin levels averaged 22.7 mg/kg 2 and 4.3 g/dl, respectively ( Table 1 ). An underweight status (BMI ＜18.5 kg/m 2 ) and an albumin level of ＜3.5 g/dl, both of which are considered to be hallmarks of malnutrition, were found in 18 (7.9%) and one (0.4%) of the 202 women, respectively. These findings suggest that the nutrition status of the elderly women evaluated in this study was not poor. Anemia with a hemoglobin level of ＜12.0 g/dl was detected in 41 women (20.3%), whereas severe anemia (hemoglobin ＜11.0 g/dl) was detected in only 11 women (5.4%). The average eGFR was 64 ml/min/1.73m 2 , and an eGFR ＜60 ml/min/1.73m 2 was observed in 66 women (33.7%). Biomarkers of inflammation were slightly but significantly elevated in the elderly women compared to the levels observed in middle-aged women (hsCRP: 17±54 μg/dl, TNF-α: 0.77±0.38 pg/ml, PAI-1: 23.9±15 ng/ml 21) . The iron levels exhibited negative associations with the levels of hsCRP and TNF-α ( Table 1) . In addition, the serum iron level was inversely associated with the levels of serum adiponectin and creatinine, while there were no associations with eGFR. Furthermore, the serum iron level was found to be inversely associated with the ratio of serum copper to zinc. However, no associations were found with the serum studies have provided strong evidence for the involvement of labile iron in oxidative stress and the pathogenesis of atherosclerosis 9, 10) . Subsequent studies, however, have failed to confirm a direct association between CVD and the iron status (See Ref. 11). In fact, some studies have raised the possibility of inverse or U-shaped associations between the iron status and various clinical cardiovascular outcomes [12] [13] [14] [15] [16] [17] [18] . In two studies, low serum iron levels were found to be associated with higher risks in women, but not in men 15, 18) . Although the amount of iron stored in the body tends to increase with age 19) , low serum iron levels frequently occur in the elderly 20) . We therefore examined the relationships between the serum iron levels and traditional and nontraditional risk factors for CVD in 202 community-living elderly women.
Subjects and Methods
We examined 202 free-living elderly women who were previously reported elsewhere 21) . The subjects were recruited as volunteers by local welfare commissioners from the city of Nishinomiya, Hyogo, Japan. No subjects were reported to have cancer, clinically diagnosed acute or chronic inflammatory diseases or endocrine, cardiovascular, hepatic or renal disorders. However, information was not available regarding drugs or nutritional supplements. Of the 202 women, 105 had hypertension (systolic/diastolic blood pressure ≧140/90 mmHg) and 14 had glucose dysregulation (casual plasma glucose ≧140 mg/dl). This study was approved by the Ethics Committee of Mukogawa Women's University, and written informed consent was obtained from all participants.
Anthropometric indices were measured between breakfast and lunch, and, thereafter, blood samples were obtained from the cubital vein. The fat mass was measured using an impedance method (InBody 430, Biospace, Tokyo, Japan).
The levels of plasma glucose, serum insulin, lipids and lipoproteins were assayed as previously reported 22, 23) . The levels of adiponectin, leptin and high-sensitivity C-reactive protein (hsCRP) were measured using respective commercially available kits, as previously reported 22, 23) . The complete blood cell count was analyzed using an automated blood cell counter (Sysmex XE-2100, Sysmex, Kobe, Japan). The serum levels of copper and iron were measured using calorimetric methods and that of zinc was measured using atomic absorptiometry. The serum creatinine level was measured enzymatically using an Autoanalyzer (AU 5200, Olympus, Tokyo, Japan). The esti-had higher creatinine levels ( Table 2 ) and lower eGFR values ( Fig. 1) , although there were no significant differences in the prevalence of chronic kidney disease between the three tertile groups (G3a: 27.7, 28.6, 20.9%, p = 0.53 and G3b: 9.2, 4.3, 4.5%, p = 0.39, in the bottom, middle and top tertiles, respectively). Finally, the women in the lowest tertile had higher serum copper levels and copper zinc ratios than those in the top tertile, whereas no differences were observed in the serum zinc levels ( Table 2) . The red blood cell count and levels of hemoglobin and hematocrit decreased ( Table 2 ) and the prevalence of anemia increased in association with decreasing serum iron levels (30.8, 18.6 and 11.9%, p = 0.024, in the bottom, middle and top tertiles, respectively). There were levels of copper or zinc. The serum iron level was positively associated with the red blood cell count and the levels of hemoglobin and hematocrit, but not with age or the albumin level. The serum iron level was not associated with BMI, abdominal girth, blood pressure or the levels of serum lipids, lipoproteins, plasma glucose or insulin.
The elderly women were divided into three groups according to tertiles of the serum iron levels ( Fig. 1 and Table 2 ). Compared to the women in the middle and top tertiles, the women in the bottom tertile had higher levels of hsCRP and TNF-α (Fig. 1) . In addition, the women in the bottom tertile had higher adiponectin levels than those in the top tertile ( Fig. 1) . Furthermore, the women in the lowest tertile independent determinants of the serum iron level (R 2 = 0.21).
Discussion
To our knowledge, this is the first report to date to assess the relationships between the serum iron level and a broad range of risk factors for CVD in elderly women. The present study demonstrated that elderly women with low serum iron levels have several nontraditional risk factors for CVD, including higher hsCRP, TNF-α, serum adiponectin and serum copper levels and copper/zinc ratios and lower kidney functions in addition to lower albumin and hemoglobin levels. Among these variables, the levels of hsCRP, TNF-α and serum adiponectin emerged as independent determinants of the serum iron level. It is noteworthy that these findings were observed in community-living elderly women who had fewer indicators of disease, such as a low BMI, hypoalbuminemia, hypocholesterolemia or renal failure, which are usually considered to be hallmarks of malnutrition and frailty 26) . In patients with overt inflammation, proinflamno differences in the prevalence of an underweight status among the three tertile groups (data not shown).
There were no differences in the serum iron levels between the women with and those without hypertension and/or glucose dysregulation (95±29 μg/dl, n=108 and 93±27 μg/dl, n=94, respectively, p=0.52).
In a multiple regression analysis including the copper/zinc ratio and the levels of hsCRP, TNF-α, adiponectin and serum creatinine as independent variables (Table 3 , model A), the levels of hsCRP, TNF-α and adiponectin emerged as independent determinants of the serum iron level. However, these three variables explained only 10.6% of the variability observed in the serum iron levels. In a model to which the hemoglobin level was further added as an independent variable (model B), the levels of hemoglobin, hsCRP and TNF-α emerged as independent determinants of the serum iron level (R 2 = 0.192). Model C included traditional risk factors, such as BMI, abdominal girth, systolic blood pressure and the levels of insulin and HDL cholesterol as independent variables in addition to those included in model A. The levels of high-sensitivity CRP and adiponectin emerged as The serum adiponectin, high-sensitivity CRP (hsCRP) and tumor-necrosis factor-α (TNF-α) levels and the estimated glomerular filtration rate (eGFR) in elderly women with serum iron levels in the bottom (black bars), middle (white bars) and top (grey bars) tertiles. The number of women in each group ranged from 65 to 70. The data are presented as the mean±standard error. Means not sharing common letters are significantly different from each other at p＜0.05 or less. hsCRP levels. An association between the CRP concentration and the risk of CVD in older adults has been previously reported 39) . Jefferis et al. 40) reported that the TNF-α level is associated with a modestly elevated risk of myocardial infarction after adjusting for established cardiovascular risk factors, although the association is not independent from an inflammatory marker, CRP. Taken together, the association between low serum iron levels and CVD mortality 12-18) may be in part mediated through inflammation.
Although the serum copper levels and copper/ zinc ratios were not found to be associated with the serum iron levels independent of low-grade inflammation, high serum copper levels and copper/zinc ratios have been shown to be associated with vascular and nonvascular disease mortality in the elderly population 41, 42) . To the best of our knowledge, there are no reports of the effects of iron therapy in elderly persons with low-grade inflammation. No changes in the CRP level in response to iron therapy have been reported in patients on dialysis 43, 44) . An association between a higher baseline CRP level and a poor response to iron supplementation has been reported in overweight children and hemodialysis patients 45, 46) . Several limitations must be acknowledged. The cross-sectional design of this study does not allow for the identification of causal relationships. The recruitment procedure may also have had an impact on the results. As participation was voluntary, women who pay more attention to their health may have been more likely to participate. Biochemical parameters, including the serum iron level, were measured only once, and data for the serum ferritin and transferrin levels were not available. The serum iron concentration, however, was used in this study as a measure of the iron status, given its high correlation coefficient with transferrin saturation (＞0.90) 47) . Information regarding nutritional supplements and drugs taken by the participants was not available; therefore, the possible contribution of supplements and drugs to the serum iron levels or other parameters cannot be completely excluded. Finally, no information was available regarding dietary intake. However, the serum albumin level and BMI were used as surrogate measures of the general nutritional status. Whether decreased serum iron levels are related more to nutrition or disease remains controversial and, especially among older people, it is difficult to distinguish the effects of undernutrition from those of disease.
In conclusion, the present study demonstrated that community-living elderly Japanese women with low serum iron levels have nontraditional risk factors matory cytokines affect iron metabolism, causing low serum iron levels without evidence of iron deficiency 27) . Interleukin-6 has been shown to induce hepatic production of hepcidin, a regulatory iron hormone, in response to inflammation 28) . Hepcidin then inhibits both the absorption of dietary iron from the intestines and the release of iron by macrophages, thereby producing low serum iron levels. Older persons are often affected by a chronic, mild proinflammatory state characterized by elevated levels of proinflammatory markers 28) . Ferrucci et al. 29) found inverse associations between the serum iron levels and the levels of interleukin-6 and CRP in older persons and hypothesized that this mild proinflammatory state may cause chronic elevation of circulating hepcidin and consequently promote low serum iron levels and anemia 29) . This hypothesis is compatible with the present observations that low serum iron levels are associated with higher levels of hsCRP and TNF-α in elderly women.
We recently reported an association between high adiponectin levels and low hemoglobin levels in community-living elderly women 21) . This finding is in accordance with the inverse association observed in the present study between the serum iron levels and the adiponectin levels independent of systemic inflammation in elderly women. However, two recent studies 30, 31) demonstrated that adipocyte iron overload represses adiponectin transcription and the serum levels of adiponectin and that, consequently, the serum levels of ferritin and transferrin are inversely associated with those of adiponectin. Although we did not measure these variables, the latter finding is compatible with the current finding of an inverse association between the serum levels of iron and adiponectin.
Higher levels or interval changes in adiponectin are positively, not negatively, associated with total and cardiovascular mortality in the elderly population [32] [33] [34] [35] [36] . Given the association between adiponectin-raising polymorphisms and exceptional longevity 37) , a leading explanation of these findings is that increases in the adiponectin level later in life represent unsuccessful attempts to compensate for age-related homeostatic decline 35, 36) . The inverse association between the serum iron and hemoglobin levels and the adiponectin levels independent of systemic inflammation in elderly women 21) led us to speculate that the association between high adiponectin levels and mortality may be mediated in part through anemia in older adults because anemia to any degree is recognized to contribute to mortality in elderly people 38) . In the present study, low serum iron levels were found to be independently associated with high for CVD, including low-grade inflammation and higher levels of serum adiponectin. Given that low serum iron levels are a risk factor for CVD and total mortality [12] [13] [14] [15] [16] [17] [18] , at least in the elderly population, a low serum iron level should not be considered an agerelated, benign phenomenon, but rather should always alert the clinician to pursue an accurate search for the responsible mechanism(s). The relationship between the serum iron levels and CVD risk factors may be affected by other factors, including low-grade inflammation, and further studies conducted in different settings with more participants are needed.
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